Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Patient Navigation × Head & Neck × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 20 Breast 12 Thoracic 10 Gynecologic 7 Tumor-Agnostic 4 Other hematologic neoplasm 3 Lymphoid 3 Genitourinary 3 Plasma cell 1 Other solid neoplasm 1 Other 1 Head & Neck 1 Endocrine 1

Conditions

Neoplasms 1 Head and Neck Neoplasms 1

Interventions

Cisplatin 513 Radiotherapy 281 pembrolizumab 273 Cetuximab 232 Radiotherapy, Intensity-Modulated 189 Docetaxel 189 Fluorouracil 164 Carboplatin 164 Paclitaxel 133 Nivolumab 118 Gemcitabine 107 Radiation 80 Magnetic Resonance Spectroscopy 77 Drug Therapy 73 toripalimab 66 Capecitabine 62 Surveys and Questionnaires 61 Surgical Procedures, Operative 58 durvalumab 53 Biopsy 52 Blood Specimen Collection 44 Cyclophosphamide 41 Chemoradiotherapy 40 camrelizumab 39 Bevacizumab 37 Standard of Care 36 Specimen Handling 36 Erlotinib Hydrochloride 36 tislelizumab 35 Radiosurgery 35

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03821064 2021-02-01

NDURE

Medical University of South Carolina

Phase NA Completed

11 enrolled 28 charts

Head and Neck Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡